Active, not recruitingPhase 3NCT01349322
Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Studying Rare malignant breast tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Radiation Therapy Oncology Group
- Principal Investigator
- Frank A. Vicini, MD, FACRSt. Joseph Mercy Oakland
- Intervention
- Standard fractionation whole breast irradiation(radiation)
- Enrollment
- 2354 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2011 – 2022
Study locations (20)
- University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
- The Kirklin Clinic at Acton Road, Birmingham, Alabama, United States
- 21st Century Oncology-Scottsdale, Scottsdale, Arizona, United States
- Mayo Clinic in Arizona, Scottsdale, Arizona, United States
- Arizona Oncology Associates-West Orange Grove, Tucson, Arizona, United States
- Banner University Medical Center - Tucson, Tucson, Arizona, United States
- CHI Saint Vincent Cancer Center Hot Springs, Hot Springs, Arkansas, United States
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park, Cameron Park, California, United States
- Mercy San Juan Medical Center, Carmichael, California, United States
- Enloe Medical Center, Chico, California, United States
- City of Hope Comprehensive Cancer Center, Duarte, California, United States
- Epic Care-Dublin, Dublin, California, United States
- 21st Century Oncology - El Segundo, El Segundo, California, United States
- +5 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01349322 on ClinicalTrials.govOther trials for Rare malignant breast tumor
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNANCT06255808Development of Assist Tool for Breast Examination Using the Principle of Ultrasonic SensorSeoul National University Hospital
- RECRUITINGNANCT06523452Laser Speckle Imaging During Breast ReconstructionRoyal Devon and Exeter NHS Foundation Trust
- RECRUITINGPHASE1NCT06239467First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast CancerOnKure, Inc.
- ACTIVE NOT RECRUITINGPHASE1NCT06206837A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.Pfizer
- ACTIVE NOT RECRUITINGNANCT06234488Multi-Institutional Transgender & Gender-Diverse Breast Cancer StudyMedical College of Wisconsin
- RECRUITINGPHASE2NCT05601440Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast CancerCanadian Cancer Trials Group
- ENROLLING BY INVITATIONNANCT07206888Advanced Ultrasound Signal Processing of Suspicious Breast ImagesJohns Hopkins University
- ACTIVE NOT RECRUITINGPHASE3NCT01674140S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast CancerSWOG Cancer Research Network